Optimizing Fluid and Oxytocin Dosing May Reduce Adverse Fetal Heart Rate Changes

Non-reassuring fetal status, often indicated by adverse fetal heart rate patterns, is a critical concern during labor, particularly following the initiation of neuraxial analgesia like combined-spinal epidural (CSE). Approximately 90% of parturients at Prentice Women's Hospital utilize CSE, which carries a reported risk of non-reassuring fetal heart traces ranging from 3% to 23%. This significant variability suggests that modifiable clinical factors, such as intravenous fluid administration and the management of exogenous oxytocin, might play a crucial role. One proposed physiological mechanism for these adverse changes is that the profound pain relief from neuraxial analgesia leads to a decrease in catecholamine release by the sympathetic nervous system. The subsequent reduction in circulating epinephrine concentration could directly impact fetal cardiovascular stability. Therefore, optimizing these specific variables could help mitigate risks and enhance the safety and quality of care for both patients and their fetuses.